04.13.2007
HealthShares™ Announces Change to the HealthShares™ European Drug Index
New York (April 13, 2007) – HealthShares™ Inc., an investment company with a series
of 20 underlying fund portfolios, today announced it has been informed by Standard &
Poor’s, the calculating agent for the HealthShares™ European Drug Index, that effective
at the opening of trading on Wednesday April 18, 2007, Solvay SA (SOLB-Brussels) and
Shire PLC (SHP-London) will replace Actavis Group (ACT-Iceland) and AES
Chemunex SA (AESCH-France) in the HealthShares™ European Drug Index. Companies
included in the European Drugs Index are headquartered in Europe and quoted on at least
one European stock exchange. The companies are engaged in the research, clinical
development, manufacturing and commercialization of pharmaceutical products, small
molecule and chemical moieties, biologics and vaccines.
HealthShares™ Announces Change to the HealthShares™ European Drug Index
<< back to news